Skip to main content
logo
Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
3.940
+0.040 (1.03%)
Sep 2, 2026, 4:00 PM EDT - Market closed

Protara Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-70.02-57.44-44.6-40.42-65.95-47.25
Depreciation & Amortization
0.340.360.330.340.250.12
Asset Writedown & Restructuring Costs
----29.52-
Loss (Gain) From Sale of Investments
-1.08-1.25-0.69-0.441.141.74
Stock-Based Compensation
4.843.834.136.096.6910.36
Other Operating Activities
1.121.081.011.011.371.05
Change in Accounts Payable
-1.03-0.871.380.850.630.04
Change in Other Net Operating Assets
-0.32-2.072.63-4.99-0.09-0.56
Operating Cash Flow
-66.13-56.37-35.81-37.56-26.46-34.5
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.36-0.09-0.06-0.05-0.12-0.6
Investment in Securities
-30.02-139.419.2253.1515.07-97.6
Investing Cash Flow
-30.38-139.4919.1653.1114.95-98.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
82.9283.73149.03---
Repurchase of Common Stock
-0.3-0.19-0.08-0.09-0.09-0.23
Other Financing Activities
-0.53-0.83-9.09---
Financing Cash Flow
82.182.72139.87-0.09-0.09-0.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-14.42-113.14123.2115.46-11.6-132.92

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-66.49-56.46-35.87-37.6-26.58-35.1
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.28-1.32-1.74-3.32-2.36-3.13
Levered Free Cash Flow
-40.49-38.48-20.39-21.88-15.16-20.23
Unlevered Free Cash Flow
-40.49-38.48-20.39-21.88-15.16-20.23

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-1.34-2.944.01-4.140.54-0.52
SEC Filings: 10-K · 10-Q